Alzheimer'S Disease Clinical Trials in Philadelphia, PA

Alzheimer'S Disease Clinical Trials in Philadelphia, PA

View the best 10 alzheimer's disease medical studies in Philadelphia, Pennsylvania. Access promising new therapies by applying to a Philadelphia-based Alzheimer'S Disease clinical trial.

Trials in Philadelphia, Pennsylvania

Here are the top 10 medical studies for alzheimer's disease in Philadelphia, Pennsylvania

Image of Barrow Neurological Institute in Phoenix, United States.

Sensory Stimulation System (GS120)

Behavioural Intervention

Recruiting1 award
This trial is an extension of a previous study where participants will receive treatment with an Active Sensory Stimulation System for up to 12 months. There will be no sham treatment or randomization in this
Image of Novo Nordisk Investigational Site in Lomita, United States.

Semaglutide

Glucagon-like peptide-1 (GLP-1) receptor agonist

Recruiting1 awardPhase 3
This trial is to test whether the medication semaglutide has a positive effect on early Alzheimer's disease. The study will last for up to 173 weeks, and participants will have 17 clinic visits and 1 phone call with the study doctor. The study includes various tests and scans, and at 10 of the clinic visits participants will have blood samples taken. The trial is only for women.
Image of Sanders-Brown Center on Aging in Lexington, United States.

Placebo +1 More

Recruiting0 awardsPhase 2
This trial will test whether a new drug can help treat early Alzheimer's.
Image of Drexel University in Philadelphia, United States.

WeCareAdvisor Study

Behavioural Intervention

Recruiting1 award9 criteria
This trial will help caregivers manage behavioral and psychological symptoms of dementia and reduce caregiver distress.
Image of Saddleback Medical Center in Orange, United States.

HELP +1 More

Behavioral Intervention

Recruiting1 award5 criteria
This trial will compare two programs to prevent delirium in older hospital patients & measure their effectiveness & implementation.
Image of MediClear Medical & Research Center, Inc. in Miami, United States.

ACP-204

Procedure

Recruiting0 awardsPhase 2 & 3
This trial tests a drug for Alzheimer's Disease Prodromal (ADP) in 3 parts, evaluating safety, efficacy, and dose response.
Image of Rhode Island Mood & Memory Research Institute in East Providence, United States.

Simufilam

Small Molecule

Recruiting2 awardsPhase 3
This trial looks at how safe a drug is over time for people who have already taken it in a previous trial.
Image of Barrow Neurological Institute /ID# 240388 in Phoenix, United States.

ABBV-916

Verified
Recruiting0 awardsPhase 2
This trial is testing a new drug called ABBV-916 to see if it can help people aged 50-90 who are in the early stages of Alzheimer's disease. Participants will receive the drug regularly over several months. The study aims to find out if the drug is safe and effective by monitoring changes in symptoms and side effects.
Image of Marlton, New Jersey in Marlton, United States.

Emraclidine

NMDA receptor antagonist

Recruiting0 awardsPhase 1
This trial is testing the safety of a drug called emraclidine, which is taken by mouth, in elderly people.
Image of Clinical Research Site in Phoenix, United States.

AVP-786

Behavioural Intervention

Verified
Recruiting1 awardPhase 3
This trial tests a combination of two drugs taken by mouth to help calm severe agitation in people with Alzheimer's disease by balancing brain chemicals.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.